Reimagining (bio)medicalization, pharmaceuticals and genetics: old critiques and new engagements
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
New York
Routledge, Taylor & Francis Group
2015
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | xi, 274 Seiten 23 cm |
ISBN: | 9781138793705 1138793701 9781138793712 113879371X |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV044019060 | ||
003 | DE-604 | ||
005 | 20170301 | ||
007 | t | ||
008 | 170128s2015 xxu |||| 00||| eng d | ||
010 | |a 014033649 | ||
020 | |a 9781138793705 |9 978-1-138-79370-5 | ||
020 | |a 1138793701 |9 1-138-79370-1 | ||
020 | |a 9781138793712 |9 978-1-138-79371-2 | ||
020 | |a 113879371X |9 1-138-79371-X | ||
035 | |a (OCoLC)976016882 | ||
035 | |a (DE-599)BVBBV044019060 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-355 | ||
050 | 0 | |a RS380 | |
082 | 0 | |a 338.4/76153 |2 23 | |
084 | |a XC 3000 |0 (DE-625)152510:12905 |2 rvk | ||
245 | 1 | 0 | |a Reimagining (bio)medicalization, pharmaceuticals and genetics |b old critiques and new engagements |c edited by Susan E. Bell & Anne E. Figert |
246 | 1 | 3 | |a Reimagining biomedicalization, pharmaceuticals and genetics |
264 | 1 | |a New York |b Routledge, Taylor & Francis Group |c 2015 | |
300 | |a xi, 274 Seiten |c 23 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
650 | 4 | |a Pharmaceutical biotechnology | |
650 | 4 | |a Biopharmaceutics | |
650 | 4 | |a Medicalization | |
650 | 4 | |a Drug Industry | |
650 | 4 | |a Drug Therapy | |
650 | 4 | |a Genetic Phenomena | |
650 | 0 | 7 | |a Pharmazie |0 (DE-588)4045705-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Biomedizin |0 (DE-588)4647152-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Genomik |0 (DE-588)4776397-8 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Genomik |0 (DE-588)4776397-8 |D s |
689 | 0 | 1 | |a Biomedizin |0 (DE-588)4647152-2 |D s |
689 | 0 | 2 | |a Pharmazie |0 (DE-588)4045705-9 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Bell, Susan E. |4 edt | |
700 | 1 | |a Figert, Anne E. |0 (DE-588)173110096 |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 9781-315-76092-6 |
856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029426630&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-029426630 |
Datensatz im Suchindex
_version_ | 1804177013909487616 |
---|---|
adam_text | REIMAGINING (BIO)MEDICALIZATION, PHARMACEUTICALS AND GENETICS
/
: 2015
TABLE OF CONTENTS / INHALTSVERZEICHNIS
(BIO)MEDICALIZATION, TECHNOSCIENCE AND HEALTH IN A TRANSNATIONAL
PERSPECTIVE : OUTLINING OLD CRITIQUES AND NEW ENGAGEMENTS / SUSAN E.
BELL AND ANNE E. FIGERT
MOVING SIDEWAYS AND FORGING AHEAD : RE-IMAGINING IZATIONS IN THE 21ST
CENTURY / SUSAN E. BELL AND ANNE E. FIGERT
A NEW BIOPOLITICS OF GENDER AND HEALTH? GENDER-SPECIFIC MEDICINE AND
PHARMACEUTICALIZATION / ELLEN ANNANDALE AND ANNE HAMMARSTROEM
REIMAGINING RACE AND ANCESTRY : BIOMEDICALIZING DIFFERENCE IN
POST-GENOMIC SUBJECTS / JANET K. SHIM, KATHERINE WEATHERFORD DARLING,
SARA L. ACKERMAN, SANDRA SOO-JIN LEE, ROBERT A. HIATT
ON STRATIFICATION AND COMPLEXITY : MATTERS OF DIFFERENCE IN THE AGE OF
BIOMEDICALIZTION / REBECCA HERZIG
VITAL OBJECTS : ESSENTIAL DRUGS AND THEIR CRITICAL LEGACIES / JEREMY
GREENE
THE DRUG SWALLOWERS : SCIENTIFIC SOVEREIGNTY AND PHARMACEUTICALIZATION
IN TWO INTERNATIONAL DRUG DONATION PROGRAMS / ARI SAMSKY
PHARMACEUTICAL TECHNOLOGIES AND THE MANAGEMENT OF BIOLOGICAL CITIZENS IN
CHILE / COURTNEY CUTHBERTSON
ESSENTIAL MEDICINES, DRUG SWALLOWERS, AND BIOLOGICAL CITIZENS : THE
ONGOING CONSTRUCTION OF PHARMACEUTICAL REGIMES / MATTHEW ARCHIBALD
BIOMEDICALIZATION AND THE NEW SCIENCE OF RACE / CATHERINE BLISS
RACIAL DESTINY OR DEXTERITY? THE GLOBAL CIRCULATION OF GENOMICS AS AN
EMPOWERMENT IDIOM / RUHA BENJAMIN
BEYOND GENETICIZATION : REGIMES OF PERCEPTIBILITY AND THE SOCIAL
DETERMINANTS OF HEALTH / SARA SHOSTAK AND MARGOT MOINESTER
THE LURE OF THE GENE / DAVID HECHT
MAPPING THE BIO-MEDICALIZED WORLD FOR JUSTICE / SUSAN REVERBY
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
any_adam_object | 1 |
author2 | Bell, Susan E. Figert, Anne E. |
author2_role | edt edt |
author2_variant | s e b se seb a e f ae aef |
author_GND | (DE-588)173110096 |
author_facet | Bell, Susan E. Figert, Anne E. |
building | Verbundindex |
bvnumber | BV044019060 |
callnumber-first | R - Medicine |
callnumber-label | RS380 |
callnumber-raw | RS380 |
callnumber-search | RS380 |
callnumber-sort | RS 3380 |
callnumber-subject | RS - Pharmacy |
classification_rvk | XC 3000 |
ctrlnum | (OCoLC)976016882 (DE-599)BVBBV044019060 |
dewey-full | 338.4/76153 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 338 - Production |
dewey-raw | 338.4/76153 |
dewey-search | 338.4/76153 |
dewey-sort | 3338.4 576153 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02150nam a2200565 c 4500</leader><controlfield tag="001">BV044019060</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170301 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170128s2015 xxu |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">014033649</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781138793705</subfield><subfield code="9">978-1-138-79370-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1138793701</subfield><subfield code="9">1-138-79370-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781138793712</subfield><subfield code="9">978-1-138-79371-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">113879371X</subfield><subfield code="9">1-138-79371-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)976016882</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044019060</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS380</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76153</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XC 3000</subfield><subfield code="0">(DE-625)152510:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Reimagining (bio)medicalization, pharmaceuticals and genetics</subfield><subfield code="b">old critiques and new engagements</subfield><subfield code="c">edited by Susan E. Bell & Anne E. Figert</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Reimagining biomedicalization, pharmaceuticals and genetics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Routledge, Taylor & Francis Group</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xi, 274 Seiten</subfield><subfield code="c">23 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biopharmaceutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicalization</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Phenomena</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazie</subfield><subfield code="0">(DE-588)4045705-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biomedizin</subfield><subfield code="0">(DE-588)4647152-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Genomik</subfield><subfield code="0">(DE-588)4776397-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Genomik</subfield><subfield code="0">(DE-588)4776397-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biomedizin</subfield><subfield code="0">(DE-588)4647152-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmazie</subfield><subfield code="0">(DE-588)4045705-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bell, Susan E.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Figert, Anne E.</subfield><subfield code="0">(DE-588)173110096</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">9781-315-76092-6</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029426630&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029426630</subfield></datafield></record></collection> |
id | DE-604.BV044019060 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:41:20Z |
institution | BVB |
isbn | 9781138793705 1138793701 9781138793712 113879371X |
language | English |
lccn | 014033649 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029426630 |
oclc_num | 976016882 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | xi, 274 Seiten 23 cm |
publishDate | 2015 |
publishDateSearch | 2015 |
publishDateSort | 2015 |
publisher | Routledge, Taylor & Francis Group |
record_format | marc |
spelling | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements edited by Susan E. Bell & Anne E. Figert Reimagining biomedicalization, pharmaceuticals and genetics New York Routledge, Taylor & Francis Group 2015 xi, 274 Seiten 23 cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Pharmaceutical biotechnology Biopharmaceutics Medicalization Drug Industry Drug Therapy Genetic Phenomena Pharmazie (DE-588)4045705-9 gnd rswk-swf Biomedizin (DE-588)4647152-2 gnd rswk-swf Genomik (DE-588)4776397-8 gnd rswk-swf Genomik (DE-588)4776397-8 s Biomedizin (DE-588)4647152-2 s Pharmazie (DE-588)4045705-9 s DE-604 Bell, Susan E. edt Figert, Anne E. (DE-588)173110096 edt Erscheint auch als Online-Ausgabe 9781-315-76092-6 LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029426630&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements Pharmaceutical biotechnology Biopharmaceutics Medicalization Drug Industry Drug Therapy Genetic Phenomena Pharmazie (DE-588)4045705-9 gnd Biomedizin (DE-588)4647152-2 gnd Genomik (DE-588)4776397-8 gnd |
subject_GND | (DE-588)4045705-9 (DE-588)4647152-2 (DE-588)4776397-8 |
title | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements |
title_alt | Reimagining biomedicalization, pharmaceuticals and genetics |
title_auth | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements |
title_exact_search | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements |
title_full | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements edited by Susan E. Bell & Anne E. Figert |
title_fullStr | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements edited by Susan E. Bell & Anne E. Figert |
title_full_unstemmed | Reimagining (bio)medicalization, pharmaceuticals and genetics old critiques and new engagements edited by Susan E. Bell & Anne E. Figert |
title_short | Reimagining (bio)medicalization, pharmaceuticals and genetics |
title_sort | reimagining bio medicalization pharmaceuticals and genetics old critiques and new engagements |
title_sub | old critiques and new engagements |
topic | Pharmaceutical biotechnology Biopharmaceutics Medicalization Drug Industry Drug Therapy Genetic Phenomena Pharmazie (DE-588)4045705-9 gnd Biomedizin (DE-588)4647152-2 gnd Genomik (DE-588)4776397-8 gnd |
topic_facet | Pharmaceutical biotechnology Biopharmaceutics Medicalization Drug Industry Drug Therapy Genetic Phenomena Pharmazie Biomedizin Genomik |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029426630&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT bellsusane reimaginingbiomedicalizationpharmaceuticalsandgeneticsoldcritiquesandnewengagements AT figertannee reimaginingbiomedicalizationpharmaceuticalsandgeneticsoldcritiquesandnewengagements AT bellsusane reimaginingbiomedicalizationpharmaceuticalsandgenetics AT figertannee reimaginingbiomedicalizationpharmaceuticalsandgenetics |